Dr. James Reynolds, Professor of Biomedical and Molecular Sciences, and Associate Dean in the School of Graduate Studies at Queen’s, has been appointed as the Interim Chief Scientific Officer of Kids Brain Health Network (KBHN).
One of the original researchers in KBHN, Dr. Reynolds has been a highly engaged in the Network in both leadership and research capacities. He has been the Program Lead for the Fetal Alcohol Spectrum Disorder research program since the inception of the Network, and has served as the Deputy Scientific Director of KBHN for the last three years.
As the Interim Chief Scientific Officer, Dr. Reynolds will provide leadership at a pivotal time for KBHN, as the Network is in the process of both finding a new permanent CSO and strategizing for the third five-year funding application to the NCE.
Based on Dr. Reynolds’s strong academic record, and his understanding and knowledge of the Network and its governance, we are confident that together with the Board and our CEO, Nicky Lewis, we have the capacity to drive KBHN to continued success.
Please join us in congratulating Dr. Reynolds on his appointment.